Takaki Shimura
Sosei BME research Lab, JapanTitle: A Neuropsychological Test Named CKPT Available on Pre-clinical Stage of Dementia
Abstract
Since
a neuropsychological test named CWPT (Color Words Pick-out test) was presented
on 2018 at the 24th International Conference on Neuroscience and
Neurochemistry, many advancements have been done. In this presentation,
diagnostic criteria using CKPT (Color Kanji Pick-out Test: Japanese version of
CWPT), application of CKPT to healthy people, examining the normality of 15
year’s large scale CKPT results are introduced. As recent new examinations
using CKPT, a health care activity for prevention of dementia, support activity
for companies who employ the aged people will be introduced, too. Finally,
tools to perform CWPT are showed for researchers who have interest in trying it
in their country.
Biography
Since
2009, Takaki Shimura founded Biomedical Research Lab. and daycare service houses
to apply his inventions to the elderly with dementia in Sosei Ltd.. Since 2000,
he worked at Tokai University as a Professor, researching mainly BME on
dementia. From 1965 to 2000, he worked in R&D field of Fujitsu Ltd. and
Fujitsu Laboratories Ltd., developing Ultrasound imaging, X-ray imaging by flat
panel detector, Remote health care system by TV etc. (2000-1979) and Fault
location diagnosis method on digital circuit, Shinkansen passenger automatic
guidance system and Laser printer (1979-1965). He graduated Tokai University
majoring Atomic Industry in 1965. He got PhD degree from Tokyo University in
1995 and Engineering fellow of the Japan Society of Ultrasound in Medicine in
2005. He is an honor director of Japan Society for Early Stage of Dementia and
the chairman of BME on Dementia Group of the Japanese Society for Medical and
Biological Engineering. My speciality is Biomedical engineering on dementia,
including detection and rehabilitation of dementia. For MCI and Preclinical
Stage of Dementia, a neuropsychological test named CWPT (Color Words Pick-out
Test) is devised and is just in use in Japan, which is attracting international
attention as a test that can detect changes in brain function before the onset
of dementia. For Dementia, We have a track record of 13 years of dementia care,
and have established a dementia care method that reduces the MMSE by only a few
points in 10 years.